Progression-Free Survival in Relapsed Multiple Myeloma Extended With Ixazomib, Data Show
Avutometinib With Defactinib for Recurrent KRAS Mutant LGSOC Completes Rolling New Drug Application
Real-World Data Confirm Ibrutinib's Role in Relapsed CLL
BE HEARD Trials Highlight Efficacy of Bimekizumab in Hidradenitis Suppurativa
FDA Approves Acoramidis for ATTR-CM
Unfavorable Health-Related Social Needs Associated With Lower Cardiovascular Health Scores
Trio of Doctors Nominated for CDC, FDA, Surgeon General
ILD, Pulmonary Sarcoidosis Burden Rose Significantly From 1990 to 2021
US Earns Another Low Grade on Maternal Health
Real-World Challenges in DMD PMO Treatment
Women Experiencing Partner Violence More Motivated to Receive PrEP
FDA Advised to Update Labels on GLP-1 Weight-Loss Drugs
Growing Awareness: Movember Ignites a Mustache Revolution for Men’s Health
Racial, Ethnic Disparities Persist in Mortality for Patients With Early-Onset CRC
Low RSV Vaccination Rates in Nursing Homes Highlight Urgent Need for Uptake
Real-World Results of Durvalumab/Tremelimumab in U-HCC Show Promise Despite Line of Therapy
Key COVID-19 Recommendations for 2024-2025 Respiratory Virus Season
Communication Can Boost Medication Persistence in PAH
Viltolarsen Slows DMD Progression in Small Study
Age-Related Disparities in Long-Term Outcomes for ER+, HER2– Breast Cancer
Edentulism May Heighten Sleep Apnea Risk
Novel Relapsed/Refractory CLL Therapies Have Similar Safety Profiles
Health Equity & Access Weekly Roundup: November 23, 2024
FDA Accepts Resubmitted NDA for Ataluren in Nonsense Duchenne Muscular Dystrophy
A Case for Iron Deficiency as a Marker of Inequality in Care Access and Treatment
In-Room Air Purifiers Could Impact RSV Incidence Among Older Adults
Addressing Patent Hurdles, Payer Barriers, and Interchangeability
Early Palliative Care Linked to Better End-of-Life Outcomes in Ovarian Cancer
AJMC® in the Press, November 22, 2024
5 Things You Should Know About Long COVID